Recall Register

Food, drugs, devices › Becton, Dickinson and Company, BD Biosciences

Device recall: CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro diagnostic used in

FDA enforcement event 72071 · Class III · initiated 27 Aug 2015 · status Terminated · terminated 9 Aug 2016

DeviceVoluntary: Firm initiated1 product recordSan Jose, CA

Becton, Dickinson and Company, BD Biosciences (San Jose, CA) initiated this device recall on 27 Aug 2015; FDA lists 1 product record under event 72071, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 4% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 9 Aug 2016. Initiation: voluntary: firm initiated. Becton, Dickinson and Company, BD Biosciences has 22 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Becton, Dickinson and Company, BD Biosciences, San Jose, CA.

Reason for recall

"CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC."

Distribution

"Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2817-2015CD4 (SK3), FITC; Contains CD4 FITC with gelatin and 0.1% sodium Azide. Catalog number 340133 in vitro diagnostic used in Hematology: The SK3 monoclonal antibody reacts with human CD4, a 59-kDa cell surface receptor expressed by a majority of thymocytes, a subpopulation of mature T helper cells, and at low levels on…128 unitsClass IIITerminated30 Sep 2015

Context

4%of 2015 device events are Class III1,153 events that year
1product record in this eventfirm median: 1
22events on this register for the firm

Other enforcement events for Becton, Dickinson and Company, BD Biosciences

InitiatedProduct (first record)TypeClassRecords
8 May 2024BD Multitest 6-Color TBNK CE-IVD, REF: 644611; BD Multitest 6-Color TBNK Kit with BD Trucount Tubes CE-IVD, REF: 337166;DeviceClass II1
25 Oct 2023CD11b APC: ASR, REF: 340936, and CE, REF: 333143DeviceClass II1
3 Oct 2022BD Trucount Tubes (Cat. No. 340334), used for determining absolute counts of leucocytes in blood. BD Trucount tubes are DeviceClass II3
25 Mar 2022BD Anti-Kappa APC (Cat. No. 341098) is an analyte specific reagent for the Anti-Kappa antibody, which specifically recogDeviceClass II2
22 Jul 2021BD" Mouse IgG2a Isotype Control APC X39 ASRDeviceClass II1
5 Oct 2020BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process control for immunophenotypingDeviceClass II1
31 Mar 2020Analyte specific reagent. REF/UDI: 641408/641408-4012-1-1 (US); 641417/641417-1157-1-01 (OUS); 641399/641399-4012-1-01 (DeviceClass II1
19 Aug 2019BD FACSLyric Flow Cytometer, 2-Laser 4 Color Instrument, REF: 662875, when using BD Trucount TubesDeviceClass II9
8 Jul 2019BD FACS Sample Prep Assistant (SPA) II - Product Usage: K050191: The BD FACSCanto system with BD FACSCanto clinical softDeviceClass II3
2 Jan 2019BD FACSLyric 3L 10C with FACSuite Clinical Software v1.1.1, catalog number 662878 BD FACSLyric is a high-performance floDeviceClass III1

All 22 events for Becton, Dickinson and Company, BD Biosciences

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "CD4 FITC label contains an error in the Spanish small text - it states CD8 FITC."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution. US nationwide (TX, CA, NC, OH, SD, PA, CT, UT, MD, TX, GA), Argentina, Taiwan, Australia, Japan, China, New Zealand, Chile and Colombia."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 9 Aug 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.